Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Living in deprived areas linked to poorer brain health

Living in a disadvantaged neighbourhood may be linked to poorer brain health, with researchers finding higher brain age, lower total brain volume and more signs of vascular damage in people living in the most deprived areas.

New research published in Radiology suggests that where people live can significantly impact their brain health. A study analyzed nearly 3,000 brain MRI scans from patients aged between 18 and 96, comparing these brain measures with an Area Deprivation Index (ADI) score. This index, which measures neighborhood-level socioeconomic disadvantage based on factors like income, education, employment, and housing, indicates the conditions of a place rather than individual residents.

The findings reveal that individuals residing in the most deprived neighborhoods exhibit a higher "brain age" and smaller total brain volume compared to those living in less deprived areas. According to John-Paul J. Yu, one of the researchers, "Where you live leaves a measurable imprint on your brain," emphasizing that an individual's environment has clear, quantifiable implications for brain age and health.

The study also uncovers higher volumes of white matter hyperintensities—bright spots on MRI scans indicative of damage to small blood vessels in the brain—in people living in the most disadvantaged neighborhoods. These hyperintensities are linked to cardiovascular damage in the brain, often resulting from prolonged exposure to factors like high blood pressure, poor sleep, and chronic stress. Higher volumes of these hyperintensities correlate with an increased risk of memory loss, cognitive problems, and dementia.

Yu underscores the importance of considering neighborhood disadvantage when developing health interventions and public policy, stating that such indices as the ADI reflect accumulated structural inequities that extend beyond individual behaviors, contributing to disparities in clinical outcomes.

Written by urgent.news from Euronews's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at euronews.com →

More in Health & Medicine

Why Omada is staying in its lane

It’s been a little more than a year since Omada Health went public, and the company reported its first profitable quarter this spring. Now, it's preparing for its first CEO transition.

More from Tuesday 15 September →